Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05489536Not ApplicableUnknown

Optimizing Gestational Weight Gain for Prevention of Gestational Diabetes Mellitus in Malaysia

Role: collaborator

NCT01832077Completed

Uptake of Telemedicine System Trial in Rual Canton

Role: collaborator

NCT01837121Not ApplicableCompleted

a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Role: collaborator

NCT01053195Not ApplicableCompleted

Qingdao Diabetes Prevention Project

Role: collaborator

NCT01743781Not ApplicableCompleted

Uptake of Comprehensive Eye Examination Trial

Role: collaborator

All 5 trials loaded